Shravanthi Reddy

Shravanthi Reddy has a diverse and impressive work experience. Shravanthi started their career as a Graduate Research Intern at Sandia National Laboratories in 2004, where they focused on computational fluid dynamics for microfluidic flow in the imprint lithography process.

In 2006, Reddy worked as a Postdoctoral Researcher at the Max Planck Institute for Intelligent Systems as a Humboldt Fellow.

Shravanthi then joined the American Association for the Advancement of Science as an AAAS Fellow and Science Advisor at the Department of Homeland Security in 2007, where they worked on forming collaborations and partnerships between international and US scientists.

Reddy's experience in industry began in 2008 when they became the VP of R&D at Sharklet Technologies Inc. Shravanthi successfully obtained funding to develop a microscopic patterning technology that inhibits microbial colonization on implantable medical devices. Shravanthi also managed a team of experts and thought leaders, developed a regulatory strategy, and engaged with clinicians and thought leaders in the field.

In 2015, Reddy became the CEO and later the Chief Operating Officer at ClearSight, a company focused on developing advanced intraocular lenses. Shravanthi played a key role in bringing the next generation of vision quality to cataract surgery patients.

From 2017, Reddy worked as the COO at Visant Medical, Inc., where they were responsible for overseeing operations.

In 2022, Reddy took the role of COO at Amaros AI before becoming the CEO of Oculotix in 2023.

Overall, Reddy's work experience demonstrates their expertise in research, development, and leadership roles in both academia and industry.

Shravanthi Reddy obtained a Bachelor of Science in Chemical Engineering from Princeton University, where they attended from 1997 to 2001. Later on, they pursued a PhD in Chemical Engineering at The University of Texas at Austin, although the specific start and end years for this degree are not provided.